Job title: Head, Microbial Assay Development
Benjamin has over 10 years of professional experience in biotechnology, bioprocessing, and method development across broad probiotic industries. Benjamin currently oversees the development, validation, and implementation of standard, novel, and rapid microbial methods that are used to evaluate product quality and stabilization for all microbial industries within Novozymes. In addition to his work at Novozymes, he is actively engaged member of the ISO community, especially within automation and novel technology. Benjamin received a Ph.D in Pharmacology with emphasis on metabolic engineering and fermentation for S. cerevisiae from University of Washington in Seattle, WA.